AxoGen (AXGN) is a medical technology company dedicated to peripheral nerve repair.
AXGN's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments.
Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed.
In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin.
AXGN provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally.
AxoGen, Inc. is headquartered in Alachua, Florida.
May 2, 2024
RegMed Investors (RMi) Closing Bell: a sigh of relief as sector adds value after earnings releases
May 2, 2024
RegMed Investors (RMi) - Q1/24 Cell and Gene Therapy Earnings Scorecard Results
May 2, 2024
RegMed Investors’ (RMi) pre-open: Don't get excited as May evolves
May 1, 2024
RegMed Investors (RMi) Closing Bell: the path forward
May 1, 2024
RegMed Investors’ (RMi) pre-open: buckle up
April 30, 2024
RegMed Investors (RMi) Closing Bell: ending April on a sour note
April 30, 2024
RegMed Investors’ (RMi) pre-open: what will be, will be
April 29, 2024
RegMed Investors (RMi) Closing Bell: a month of up, downs; I thought were exercise
April 29, 2024
RegMed Investors’ (RMi) pre-open: waiting and watching for the exhale of share pricing value
35 companies, 1 interpreter!
Insight, foresight and recommendation
AxoGen, Inc. (AXGN) – January '18 opened at $27.95 with an upside of $28.05 on 2/1 while dropping to $27.40 on 2/16 ... since November of '17 appreciation has withstood mild drags to the downside ...
buyMy motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors